Back
Product details:
CAS
1254053-43-4
Purity
95%
Gilteritinib is a potent selective inhibitor of both of the mutations, internal tandem duplication and tyrosine kinase domain, of the FLT3 receptor. It is used to treat relapsed or refractory acute myeloid leukemia.
Properties
Name
Gilteritinib
Smiles
CCC=1N=C(C(=O)N)C(NC=2C=CC(N3CCC(CC3)N4CCN(C)CC4)=C(OC)C2)=NC1NC5CCOCC5
Targets
Please log in to see this information
SDS
ASP-2215 | gilteritinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$56
35 mg
$59
40 mg
$61
45 mg
$64
50 mg
$66
75 mg
$69
100 mg
$POA
Quantity
1
Total amount
$ 41
ASP-2215 | gilteritinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.